EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives

Mohammed Alrouji iD, Mohammed S Alshammari, Syed Tasqeeruddin iD, Anas Shamsi iD

Antioxidants · 24.06.2025 · 14 (7) · 774

DOI: 10.3390/antiox14070774 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 24.06.2025. Verfasst von Mohammed Alrouji und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ajman University, King Khalid University, Shaqra University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is a key risk factor for neurodegenerative disorders and is associated with widespread systemic and brain-specific changes. Alzheimer’s disease (AD), a progressive and irreversible brain disorder, primarily affects older adults and leads to a gradual decline in cognitive function. The underlying disease mechanisms often begin years before clinical symptoms appear, limiting the effectiveness of current treatments. Several factors linked to aging—including inflammation, oxidative stress, impaired metabolism, and protein aggregation—contribute to the onset and progression of AD. A central feature of AD is the abnormal accumulation of amyloid beta (Aβ) and tau, a microtubule-associated protein, driven by post-translational modifications such as acetylation and hyperphosphorylation. These modifications lead to structural changes in tau, promoting the formation of neurofibrillary tangles (NFTs), which are more closely associated with cognitive decline than Aβ plaques. Interestingly, tau accumulation and the resulting cognitive impairments are often observed in aged individuals without Aβ deposition, highlighting tauopathy as a distinct contributor to age-related cognitive decline. This review focuses on new developments in therapeutic approaches that target oxidative stress, protein aggregation, and neuroinflammation, and our current understanding of the molecular pathways relating aging and tau pathology in AD.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseagingamyloid-βneuroinflammationoxidative stresstau pathologytau phosphorylation

Autor:innen und Institutionen

  • Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha 62521, Saudi Arabia.
  • Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates.

ORCID-Profile: Mohammed Alrouji, Syed Tasqeeruddin, Anas Shamsi

Förderung

  • Ajman University
  • King Khalid University
  • Shaqra University

Zitieren

APA

Alrouji, M., Alshammari, M. S., Tasqeeruddin, S., & Shamsi, A. (2025). Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives. Antioxidants, 14(7), 774. https://doi.org/10.3390/antiox14070774

Vancouver

Alrouji M, Alshammari MS, Tasqeeruddin S, Shamsi A. Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives. Antioxidants. 2025;14(7):774. doi:10.3390/antiox14070774

BibTeX
@article{Alrouji2025,
  author = {Alrouji, Mohammed and Alshammari, Mohammed S and Tasqeeruddin, Syed and Shamsi, Anas},
  title = {Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {7},
  pages = {774},
  doi = {10.3390/antiox14070774}
}
Kostenlos starten →